General Information of the Compound
Compound ID
CP0112369
Compound Name
(8S,9S,10R,13S,14S,17S)-17-(tert-butylcarbamoyl)-10,13-dimethyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3-carboxylic acid
    Show/Hide
Synonyms
Epristeride
ONO-9302
SKB-105657
SKF-105657
Zariflo
    Show/Hide
Structure
Formula
C25H37NO3
Molecular Weight
399.575
Canonical SMILES
CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C=C(CC[C@]4(C)[C@H]3CC[C@]12C)C(O)=O
    Show/Hide
InChI
InChI=1S/C25H37NO3/c1-23(2,3)26-21(27)20-9-8-18-17-7-6-16-14-15(22(28)29)10-12-24(16,4)19(17)11-13-25(18,20)5/h6,14,17-20H,7-13H2,1-5H3,(H,26,27)(H,28,29)/t17-,18-,19-,20+,24-,25-/m0/s1
    Show/Hide
InChIKey
VAPSMQAHNAZRKC-PQWRYPMOSA-N
CAS
119169-78-7
Physicochemical Property
logP
5.101
Rotatable Bonds
2
Heavy Atom Count
29
Polar Areas
66.4
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
2
Complexity
29

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 68741
SID: 12014629
ChEMBL ID
CHEMBL138225
Clinical Information about the Compound
Drug 1 ( Epristeride )
Drug Name Epristeride
Company SmithKline Beecham plc
Indication
Hirsutism
Phase 3